MPS PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of MPS Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.57₹ 0.01
As on Dec 15, 2025, 4:01 PM IST
MPS Pharma Price Performance
Today's LowToday's High
₹1.76₹1.77
₹1.77
52 Weeks' Low52 Weeks' High
₹1.76₹4.33
₹1.77
Open Price
₹1.76
Prev. Close
₹1.76
Volume
2,517
Over the last 5 years, the share price of MPS Pharma has gained 36.76% CAGR. Over the past year, the corresponding return has been -58.74%.
MPS Pharma’s current P/E of -3.79x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
MPS Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| MPS Pharma | 0 | -3.80 | -11.06 | -38.33 | -58.74 | -2.51 | 36.76 |
| Sun Pharmaceutical Industries | 0.32 | 1.60 | 10.60 | 8.68 | 0.14 | 21.96 | 25.69 |
| Divi's Laboratories | -0.03 | -3.56 | 3.97 | -3.76 | 7.56 | 23.41 | 10.46 |
| Torrent Pharmaceuticals | -0.96 | -1.58 | 6.01 | 15.51 | 11.14 | 33.01 | 22.19 |
| Cipla | 0.56 | -2.53 | -3.96 | -0.40 | 3.24 | 10.95 | 13.84 |
| Dr. Reddy's Laboratories | 1.59 | 2.13 | -3.05 | -3.64 | 1.84 | 13.05 | 4.60 |
| Lupin | 2.66 | 2.83 | 3.87 | 8.55 | 3.12 | 42.53 | 16.80 |
| Zydus Lifesciences | -0.63 | -1.76 | -11.31 | -4.28 | -5.33 | 30.89 | 14.08 |
| Mankind Pharma | -1.74 | -6.00 | -17.85 | -10.30 | -20.70 | 14.01 | 8.18 |
| Aurobindo Pharma | 1.51 | -3.89 | 8.47 | 7.17 | -2.01 | 39.53 | 6.40 |
| Alkem Laboratories | 0.29 | -1.90 | 2.54 | 16.65 | 4.19 | 23.22 | 13.84 |
| Abbott India | -1.25 | -6.50 | -10.56 | -12.97 | -1.18 | 9.86 | 11.43 |
| Glenmark Pharmaceuticals | -0.48 | 4.17 | -4.83 | 17.52 | 28.48 | 67.13 | 30.30 |
| Laurus Labs | -0.88 | -1.28 | 12.95 | 52.78 | 76.64 | 37.55 | 24.16 |
| Biocon | 2.02 | -8.24 | 9.09 | 9.66 | 10.19 | 13.70 | -3.45 |
| GlaxoSmithKline Pharmaceuticals | -0.44 | 3.57 | -5.68 | -20.67 | 13.92 | 24.68 | 10.23 |
| Anthem Biosciences | 3.03 | -0.26 | -23.13 | -9.12 | -9.12 | -3.14 | -1.89 |
| Ipca Laboratories | -5.00 | -4.91 | 6.04 | 2.52 | -10.70 | 17.64 | 5.16 |
| Ajanta Pharma | -1.89 | 4.06 | 1.69 | 2.29 | -9.32 | 30.31 | 18.76 |
| J B Chemicals & Pharmaceuticals | -1.77 | -2.36 | 5.02 | 3.09 | -2.66 | 20.00 | 26.95 |
Over the last one year, MPS Pharma has declined 58.74% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, MPS Pharma has outperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).
MPS Pharma Financials
MPS Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1.82 | 1.81 |
| 10 | 1.94 | 1.89 |
| 20 | 2.08 | 2.08 |
| 50 | 2.84 | 2.55 |
| 100 | 3.13 | 2.72 |
| 200 | 2.43 | 2.52 |
MPS Pharma Share Holding Pattern
In the latest quarter, MPS Pharma remained same as its previous close in promoter holding, while DII stake unchanged at 0.58%, FII holding unchanged at 0.00%, and public shareholding moved down to 63.52% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
MPS Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 20, 2025, 2:09 AM IST | MPS Pharma - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 And A |
| Nov 14, 2025, 8:23 PM IST | MPS Pharma - Results As On 30.09.2025 |
| Nov 14, 2025, 8:16 PM IST | MPS Pharma - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Standalone Un-Audited Financial Results |
| Nov 05, 2025, 1:39 AM IST | MPS Pharma - Board Meeting Intimation for Notice Of Board Meeting To Consider The Un-Audited Financial Results Of The Company |
| Oct 14, 2025, 7:51 PM IST | MPS Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About MPS Pharma
MPS Pharma Ltd. is a Public Limited Listed company incorporated on 09/09/1994 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74899HR1994PLC038300 and registration number is 038300. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 19.11 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address138, Roz-Ka-Meo Industrial Area, Sohna, Mewat Dist. Haryana 122103
- Contact
Management
- Mr. Peeyush Kumar AggarwalManaging Director
- Mr. Ram Niwas SharmaNon Independent Director
- Ms. Madhu SharmaIndependent Director
- Mr. Ajay SharmaIndependent Director
FAQs on MPS Pharma Share Price
What is the share price of MPS Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for MPS Pharma is ₹1.77 as on Dec 15, 2025.
What kind of stock is MPS Pharma?
The MPS Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of MPS Pharma?
The market cap of MPS Pharma is ₹3.38 Cr as on Dec 15, 2025.
What are today's High and Low prices of MPS Pharma?
Today’s highest and lowest price of MPS Pharma are ₹1.77 and ₹1.76.
What are the 52 Week High and 52 Week Low of MPS Pharma?
The 52-week high/low is the highest and lowest price at which MPS Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of MPS Pharma is ₹4.33 and 52-week low of MPS Pharma is ₹1.76 as on Dec 15, 2025.
How has the MPS Pharma performed historically in terms of returns?
The MPS Pharma has shown returns of 0.57% over the past day, -3.8% for the past month, -11.06% over 3 months, -58.74% over 1 year, -2.51% across 3 years, and 36.76% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of MPS Pharma?
P/E ratio of and PB ratio of MPS Pharma are -3.79 and 3.13 on Dec 15, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse